Skip to main content

VIRULENCIA Y PATOGENICIDAD EN MICOPLASMAS DEL CLUSTER PNEUMONIAE. DESARROLLLO DE UN FARMACO ANTIADHESON PARA TERAPIA ANTIMICROBIANA

PID2021-125632OB-C22

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Moonlighting Proteins, Some Hypotheses on the Structural Origin of Their Multifunctionality

  • Cedano, Juan|||0000-0003-1380-8036
  • Huerta Casado, Mario
  • Mozo-Villarias, Angel|||0000-0001-6559-7926
  • Querol Murillo, Enrique|||0000-0002-3658-3434
Moonlighting proteins-single polypeptides performing multiple, often unrelated functions-are increasingly recognized as key players in human disease and microbial pathogenesis, making their identification crucial for understanding disease mechanisms and developing targeted therapies. This study addresses the unresolved question of how such multifunctionality evolves, focusing on two potential structural mechanisms: Non-Orthologous Gene Displacement/Non-Homologous Isofunctional Enzymes (NOGD/NHIE), where evolutionarily unrelated proteins perform the same function, and Fold-Switching Proteins (FSP), which adopt alternative secondary structures to switch functions without sequence changes. We analyzed the overlap between known human moonlighting proteins (from MultitaskProtDB-II) and curated datasets of NOGD/NHIE (Non-Orthologous Gene Displacement/Non-Homologous Isofunctional Enzymes) and fold-switching proteins (FSPs), using Fisher's exact test for statistical validation. Moonlighting proteins showed extraordinary enrichment for NOGD/NHIE (19.89% vs. 0.39% in non-moonlighting proteins; odds ratio = 63.1, p < 2.2 × 10 -16) and strong enrichment for FSPs (6.99% vs. 0.26%; odds ratio = 28.7, p = 1.13 × 10 -14), corresponding to ~51-fold and ~27-fold higher risks, respectively. These findings establish intrinsic structural plasticity-whether through evolutionary replacement (NOGD/NHIE) or conformational switching (FSP)-as a central mechanism enabling functional moonlighting in the human proteome. The results suggest that such plasticity facilitates functional innovation while preserving sequence integrity, and that both NOGD/NHIE and FSP features may serve as predictive signatures for identifying novel moonlighting proteins, particularly those with implications for disease mechanisms and therapeutic targeting.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions

  • Vizarraga, David|||0000-0002-4478-0155
  • Marcos, Marina
  • Rotllan, Noemi|||0000-0002-0587-8045
  • Martín Sánchez, Jesús|||0000-0003-4250-4824
  • Santos, David|||0000-0003-1157-4969
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Soto, Begoña|||0000-0002-5965-1292
  • Guerra, Pablo|||0000-0002-0154-3862
  • Wu, Wanlu
  • Serrano, Luis|||0000-0002-5276-1392
  • Piñol Ribas, Jaume|||0000-0002-9055-8934
  • Fita, Ignacio|||0000-0002-7521-2679
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Velasco Reniu, Lorena|||0009-0002-6326-4532
  • Pareja, Félix
  • Collantes, María
  • Rodriguez Arce, Irene
Mycoplasma pneumoniae (MPN) i s a bacterial pathogen that primarily causes atypical pneumonia. It cannot synthesize certain essential lipids and therefore relies on the host for their acquisition to survive. MPN has been detected in increased amounts within ruptured atherosclerotic plaques. In this work, we show that the protein P116 facilitates cholesterol acquisition from LDL, HDL and various cell types. Targeting P116's C-terminal domain with a monoclonal antibody inhibits cholesterol acquisition and bacterial growth in vitro. Phase contrast epifluorescence microscopy of human arteries reveals that this antibody blocks MPN binding to atherosclerotic lesions ex vivo. Additionally, an MPN chassis injected into hyperlipidemic female mice localizes to the liver and atherosclerotic plaques. Here, we report that P116 plays a role in extracting essential lipids from lipoproteins and host cells and regulates MPN localization to atheromatous plaques. The study highlights MPN 's potential as a tool for targeting atherosclerotic lesions and fatty liver. In this work, the authors show that the essential Mycoplasma pneumoniae protein P116 enables cholesterol acquisition from lipoproteins and various cell types. An antibody against its C-terminal domain inhibits lipid acquisition, growth, and plaque binding, linking M. pneumoniae to atherosclerotic lipid-rich tissue.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions

  • Vizarraga, David
  • Marcos, Marina
  • Rotllan, Noemí
  • Martín, Jesús
  • Santos, David
  • Camacho, Mercedes
  • Soto, Begoña
  • Velasco-Reniu, Lorena
  • Guerra, Pablo
  • Pareja, Félix
  • Collantes, María
  • Wu, Wanlu
  • Rodriguez-Arce, Irene
  • Serrano Pubull, Luis, 1982-
  • Piñol, Jaume
  • Fita, Ignacio
  • Escolà-Gil, Joan Carles
Mycoplasma pneumoniae (MPN) is a bacterial pathogen that primarily causes atypical pneumonia. It cannot synthesize certain essential lipids and therefore relies on the host for their acquisition to survive. MPN has been detected in increased amounts within ruptured atherosclerotic plaques. In this work, we show that the protein P116 facilitates cholesterol acquisition from LDL, HDL and various cell types. Targeting P116's C-terminal domain with a monoclonal antibody inhibits cholesterol acquisition and bacterial growth in vitro. Phase contrast epifluorescence microscopy of human arteries reveals that this antibody blocks MPN binding to atherosclerotic lesions ex vivo. Additionally, an MPN chassis injected into hyperlipidemic female mice localizes to the liver and atherosclerotic plaques. Here, we report that P116 plays a role in extracting essential lipids from lipoproteins and host cells and regulates MPN localization to atheromatous plaques. The study highlights MPN's potential as a tool for targeting atherosclerotic lesions and fatty liver., This work was partly funded by the Instituto de Salud Carlos III and FEDER "Una manera de hacer Europa" grant PI2300232 (to J.E.-G.). N.R. was funded by Agencia Estatal de Investigación (AEI/10.13039/501100011033 and CNS2023-144119) within the Subprograma Ramón y Cajal (RYC-201722879) and by MICINN-Spain grant PID2022-137186OB-I00. CIBERDEM is an Instituto de Salud Carlos III project. I.F. and J.P. were funded by MICINN-Spain grant PID2021-125632OB-C21 and PID2021-125632OB-C22. The authors acknowledge funding from Project, IU16-014045 (CRYO-TEM) from Generalitat de Catalunya, and by "ERDF A way of making Europe", by the European Union.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas

  • Sprankel, Lasse
  • Vizarraga, David
  • Martín, J.
  • Manger, Sina
  • Meier-Credo, Jakob
  • Marcos, Marina
  • Julve, Josep
  • Rotllan, Noemi
  • Scheffer, Margot P.
  • Escolà-Gil, Joan Carles
  • Langer, Julian D.
  • Piñol, Jaume
  • Fita, Ignacio
  • Frangakis, Achilleas S.
Mycoplasma pneumoniae, responsible for approximately 30% of community-acquired human pneumonia, needs to extract lipids from the host environment for survival and proliferation. Here, we report a comprehensive structural and functional analysis of the previously uncharacterized protein P116 (MPN_213). Single-particle cryo-electron microscopy of P116 reveals a homodimer presenting a previously unseen fold, forming a huge hydrophobic cavity, which is fully accessible to solvent. Lipidomics analysis shows that P116 specifically extracts lipids such as phosphatidylcholine, sphingomyelin and cholesterol. Structures of different conformational states reveal the mechanism by which lipids are extracted. This finding immediately suggests a way to control Mycoplasma infection by interfering with lipid uptake., We thank L. Company and I. Fernández-Vidal for their support during MALS and mass spectroscopy measurements, A. Iborra (Servei de Cultius Cellulars, Anticossos Citometria, UAB) for his assistance with immunizing mice, D. Santos for his assistance in the radioactivity experiment and R. Pérez-Luque and D. Aparicio for their constant support and discussions. J. P. was funded by grants BIO2017-84166-R and PID2021-125632OB-C22 from the ministerio de Ciencia, Innovación y Universidades (MICINN, Spain). I. F. was funded by MICINN-Spain grant PID2021-125632OB-C21. A. S. F. was supported by the Deutsche Forschungsgemeinschaft (FR 1653/14-1 for MS and, FR 1653/6-3 for LS) and the Research Training Group iMOL (GRK 2566/1 for SM)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dynamics of the adhesion complex of the human pathogens Mycoplasma pneumoniae and Mycoplasma genitalium

  • Vizarraga, David
  • Kawamoto, Akihiro
  • Marcos-Silva, Marina
  • Martín, Jesús
  • Makino, Fumiaki
  • Miyata, Tomoko
  • Roel-Touris, Jorge
  • Marcos, Enrique
  • Pich, Oscar Q.
  • Aparicio, David
  • Fita, Ignacio
  • Miyata, Makoto
  • Piñol, Jaume
  • Namba, Keiichi
  • Kenri, Tsuyoshi
Mycoplasma pneumoniae and Mycoplasma genitalium are bacterial wall-less human pathogens and the causative agents of respiratory and reproductive tract infections. Infectivity, gliding motility and adhesion of these mycoplasmas to host cells are mediated by orthologous adhesin proteins forming a transmembrane adhesion complex that binds to sialylated oligosaccharides human cell ligands. Here we report the cryo-EM structure of M. pneumoniae P1 adhesin bound to the Fab fragment of monoclonal antibody P1/MCA4, which stops gliding and induces detachment of motile cells. The epitope of P1/MCA4 involves residues only from the small C-domain of P1. This epitope is accessible to antibodies only in the “closed conformation” of the adhesion complex and is not accessible in the “open” conformation, when the adhesion complex is ready for attachment to sialylated oligosaccharides. Polyclonal antibodies generated against the large N-domain of P1 or against the whole ectodomain of P40/P90 have little or no effects on adhesion or motility. Moreover, mutations in the highly conserved Engelman motifs found in the transmembrane helix of M. genitalium P110 adhesin also alter adhesion and motility. These results show that antibodies directed to the C-domain of P1 hinder the large conformational rearrangements in this domain required to alternate between the “open” and “closed” conformations of the adhesion complex. Since transition between both conformations is essential to complete the attachment/detachment cycle of the adhesion complex, interfering with the gliding of mycoplasma cells and providing a new potential target to confront M. pneumoniae and M. genitalium infections., E.M. was supported by grants RYC2018-025295-I and PID2020-120098GA-I00, I. F. and J. P. were supported by grants PID2021-125632OB-C21 and -C22 from the Spanish Ministry of Science and Innovation. K.N. was supported by grants JP23am121003 of Research Support Project for Life Science and Drug Discovery (BINDS) from AMED and by JEOL YOKOGUSHI Research Alliance Laboratories of Osaka University. T.K. was supported by Grants-in-Aid for Scientific Research (15H01337 and 22K07063) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grant 24fk0108697j0101 from the Japan Agency for Medical Research and Development., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions

  • Vizarraga, David
  • Marcos, Marina
  • Rotllan, Noemi
  • Martín, Jesús
  • Santos, David
  • Camacho, Mercedes
  • Soto, Begoña
  • Velasco-Reniu, Lorena
  • Guerra, Pablo
  • Pareja, Félix
  • Collantes, María
  • Wu, Wanlu
  • Rodríguez-Arce, Irene
  • Serrano, Luis
  • Piñol, Jaume
  • Fita, Ignacio
  • Escolà-Gil, Joan Carles
Mycoplasma pneumoniae (MPN) is a bacterial pathogen that primarily causes atypical pneumonia. It cannot synthesize certain essential lipids and therefore relies on the host for their acquisition to survive. MPN has been detected in increased amounts within ruptured atherosclerotic plaques. In this work, we show that the protein P116 facilitates cholesterol acquisition from LDL, HDL and various cell types. Targeting P116’s C-terminal domain with a monoclonal antibody inhibits cholesterol acquisition and bacterial growth in vitro. Phase contrast epifluorescence microscopy of human arteries reveals that this antibody blocks MPN binding to atherosclerotic lesions ex vivo. Additionally, an MPN chassis injected into hyperlipidemic female mice localizes to the liver and atherosclerotic plaques. Here, we report that P116 plays a role in extracting essential lipids from lipoproteins and host cells and regulates MPN localization to atheromatous plaques. The study highlights MPN’s potential as a tool for targeting atherosclerotic lesions and fatty liver., This work was partly funded by the Instituto de Salud Carlos III and FEDER “Una manera de hacer Europa” grant PI2300232 (to J.E.-G.). N.R. was funded by Agencia Estatal de Investigación (AEI/10.13039/501100011033 and CNS2023-144119) within the Subprograma Ramón y Cajal (RYC-201722879) and by MICINN-Spain grant PID2022-137186OB-I00. CIBERDEM is an Instituto de Salud Carlos III project. I.F. and J.P. were funded by MICINN-Spain grant PID2021-125632OB-C21 and PID2021-125632OB-C22. The authors acknowledge funding from Project, IU16-014045 (CRYO-TEM) from Generalitat de Catalunya, and by “ERDF A way of making Europe”, by the European Union., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions

  • Vizarraga, David
  • Marcos, Marina
  • Rotllan, Noemí
  • Martín, Jesús
  • Santos, David
  • Camacho, Mercedes
  • Soto, Begoña
  • Velasco-Reniu, Lorena
  • Guerra, Pablo
  • Pareja, Félix
  • Collantes, María
  • Wu, Wanlu
  • Rodriguez-Arce, Irene
  • Serrano Pubull, Luis, 1982-
  • Piñol, Jaume
  • Fita, Ignacio
  • Escolà-Gil, Joan Carles
Mycoplasma pneumoniae (MPN) is a bacterial pathogen that primarily causes atypical pneumonia. It cannot synthesize certain essential lipids and therefore relies on the host for their acquisition to survive. MPN has been detected in increased amounts within ruptured atherosclerotic plaques. In this work, we show that the protein P116 facilitates cholesterol acquisition from LDL, HDL and various cell types. Targeting P116's C-terminal domain with a monoclonal antibody inhibits cholesterol acquisition and bacterial growth in vitro. Phase contrast epifluorescence microscopy of human arteries reveals that this antibody blocks MPN binding to atherosclerotic lesions ex vivo. Additionally, an MPN chassis injected into hyperlipidemic female mice localizes to the liver and atherosclerotic plaques. Here, we report that P116 plays a role in extracting essential lipids from lipoproteins and host cells and regulates MPN localization to atheromatous plaques. The study highlights MPN's potential as a tool for targeting atherosclerotic lesions and fatty liver., This work was partly funded by the Instituto de Salud Carlos III and FEDER "Una manera de hacer Europa" grant PI2300232 (to J.E.-G.). N.R. was funded by Agencia Estatal de Investigación (AEI/10.13039/501100011033 and CNS2023-144119) within the Subprograma Ramón y Cajal (RYC-201722879) and by MICINN-Spain grant PID2022-137186OB-I00. CIBERDEM is an Instituto de Salud Carlos III project. I.F. and J.P. were funded by MICINN-Spain grant PID2021-125632OB-C21 and PID2021-125632OB-C22. The authors acknowledge funding from Project, IU16-014045 (CRYO-TEM) from Generalitat de Catalunya, and by "ERDF A way of making Europe", by the European Union.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Role of Moonlighting Proteins in Disease, Analyzing the Contribution of Canonical and Moonlighting Functions in Disease Progression

  • Huerta Casado, Mario
  • Franco Serrano, Luis|||0000-0002-7308-7333
  • Amela Abellan, Isaac
  • Pérez-Pons, Josep A.|||0000-0002-5062-2989
  • Piñol Ribas, Jaume|||0000-0002-9055-8934
  • Mozo-Villarias, Angel|||0000-0001-6559-7926
  • Querol Murillo, Enrique|||0000-0002-3658-3434
  • Cedano, Juan|||0000-0003-1380-8036
The term moonlighting proteins refers to those proteins that present alternative functions performed by a single polypeptide chain acquired throughout evolution (called canonical and moonlighting, respectively). Over 78% of moonlighting proteins are involved in human diseases, 48% are targeted by current drugs, and over 25% of them are involved in the virulence of pathogenic microorganisms. These facts encouraged us to study the link between the functions of moonlighting proteins and disease. We found a large number of moonlighting functions activated by pathological conditions that are highly involved in disease development and progression. The factors that activate some moonlighting functions take place only in pathological conditions, such as specific cellular translocations or changes in protein structure. Some moonlighting functions are involved in disease promotion while others are involved in curbing it. The disease-impairing moonlighting functions attempt to restore the homeostasis, or to reduce the damage linked to the imbalance caused by the disease. The disease-promoting moonlighting functions primarily involve the immune system, mesenchyme cross-talk, or excessive tissue proliferation. We often find moonlighting functions linked to the canonical function in a pathological context. Moonlighting functions are especially coordinated in inflammation and cancer. Wound healing and epithelial to mesenchymal transition are very representative. They involve multiple moonlighting proteins with a different role in each phase of the process, contributing to the current-phase phenotype or promoting a phase switch, mitigating the damage or intensifying the remodeling. All of this implies a new level of complexity in the study of pathology genesis, progression, and treatment. The specific protein function involved in a patient's progress or that is affected by a drug must be elucidated for the correct treatment of diseases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas

  • Sprankel, Lasse
  • Vizarraga, David|||0000-0002-4478-0155
  • Martín Sánchez, Jesús|||0000-0003-4250-4824
  • Manger, Sina
  • Meier-Credo, Jakob|||0000-0003-1026-1573
  • Marcos, Marina
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Rotllan, Noemi|||0000-0002-0587-8045
  • Scheffer, Margot P.
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Langer, Julian D.|||0000-0002-5190-577X
  • Piñol Ribas, Jaume|||0000-0002-9055-8934
  • Fita, Ignacio|||0000-0002-7521-2679
  • Frangakis, Achilleas S.|||0000-0002-8067-6611
Mycoplasma pneumoniae, responsible for approximately 30% of community-acquired human pneumonia, needs to extract lipids from the host environment for survival and proliferation. Here, we report a comprehensive structural and functional analysis of the previously uncharacterized protein P116 (MPN_213). Single-particle cryo-electron microscopy of P116 reveals a homodimer presenting a previously unseen fold, forming a huge hydrophobic cavity, which is fully accessible to solvent. Lipidomics analysis shows that P116 specifically extracts lipids such as phosphatidylcholine, sphingomyelin and cholesterol. Structures of different conformational states reveal the mechanism by which lipids are extracted. This finding immediately suggests a way to control Mycoplasma infection by interfering with lipid uptake.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

How hydrophobicity shapes the architecture of protein assemblies

  • Cedano, Juan|||0000-0003-1380-8036
  • Querol Murillo, Enrique|||0000-0002-3658-3434
  • Mozo-Villarias, Angel|||0000-0001-6559-7926
The interactions that give rise to protein self-assembly are basically electrical and hydrophobic in origin. The electrical interactions are approached in this study as the interaction between electrostatic dipoles originated by the asymmetric distribution of their charged amino acids. However, hydrophobicity is not easily derivable from basic physicochemical principles. Its treatment is carried out here considering a hydrophobic force field originated by "hydrophobic charges". These charges are indices obtained experimentally from the free energies of transferring amino acids from polar to hydrophobic media. Hydrophobic dipole moments are used here in a manner analogous to electric dipole moments, and an empirical expression of interaction energy between hydrophobic dipoles is derived. This methodology is used with two examples of self-assembly systems of different complexity. It was found that the hydrophobic dipole moments of proteins tend to interact in such a way that they align parallel to each other in a completely analogous way to how phospholipids are oriented in biological membranes to form the well-known double layer. In this biological membrane model (BM model), proteins tend to interact in a similar way, although in this case this alignment is modulated by the tendency of the corresponding electrostatic dipoles to counter-align.